|1.||Costa, Karina A: 2 articles (04/2007 - 01/2002)|
|2.||Coelho, Márcio M: 2 articles (04/2007 - 01/2002)|
|3.||Bertollo, Caryne M: 2 articles (04/2007 - 01/2002)|
|4.||Garavito, R Michael: 1 article (02/2009)|
|5.||Gao, Feng: 1 article (02/2009)|
|6.||Wang, Donna H: 1 article (02/2009)|
|7.||Sui, Dexin: 1 article (02/2009)|
|8.||Worden, R Mark: 1 article (02/2009)|
|9.||Nascimento, Elias B: 1 article (04/2007)|
|10.||Rocha, Leonardo Tadeu S: 1 article (04/2007)|
10/01/1991 - "The present study demonstrates an inverse correlation between in vivo age and the in vitro morphological and proliferative response of Syrian hamster dermal fibroblasts to the tumor promoter phorbol-12,13-didecanoate. "
09/01/1982 - "Studies were made of the effects of the potent tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA), 4-O-methyl TPA (4-O-MeTPA), and 4 alpha phorbol 12,13-didecanoate (4 alpha PDD) on the aggregation of embryonic chick cells in gyratory shaker culture, a model system useful for the study of cell adhesion and cell interactions. "
01/01/1989 - "Addition of the phorbol ester tumor promoter, phorbol-12,13-didecanoate, rescued proliferation and focus-formation by these nuclear oncogenes-transformed cell lines. "
01/01/1988 - "Addition of a phorbol ester tumor promoter, phorbol-12,13-didecanoate, efficiently rescued proliferation and focus formation by myc-transformed cells. "
12/01/1986 - "Coepibolin activity appears to associate with tumor-promoting activity in that the phorbol derivative, phorbol-12,13-didecanoate, shows coepibolin activity, while its inactive non-tumor-promoting isomer, phorbol-4 alpha-phorbol-12,13-didecanoate, does not. "
05/15/1989 - "Studies we have done to identify the cellular substrate(s) of the lymphoma plasma membrane-associated PKC have shown that GP85 is preferentially phosphorylated in isolated membrane preparations following addition of the PKC activator, TPA (phorbol-12-O-tetradecanoyl-phorbol 13-acetate), but not the biologically inactive TPA analogue, 4 alpha-PDD (4 alpha-phorbol 12,13-didecanoate). "
01/01/2002 - "2. Intraplantar injection of phorbol-12,13-didecanoate (PDD; 0.01, 0.1 or 1 microg), a PKC activator, but not of 4 alpha-PDD (inactive analogue), dose-dependently induced thermal hyperalgesia in rats. "
04/30/2007 - "Fenofibrate did not inhibit mechanical allodynia or paw edema induced by phorbol-12,13-didecanoate (PDD), a protein kinase C activator, in rats. "
|6.||Small Interfering RNA (siRNA)
|9.||Conditioned Culture Media
|10.||Arachidonic Acid (Vitamin F)